2021 MedCan Speaker

Mark Lucas

Chief Executive Officer,
Cannasouth

Mark heads up the first NZX listed medicinal cannabis company, Cannasouth. 
 Based in the Waikato, Mark and the team have established state-of-the-art research laboratories and cannabis cultivation facilities. 

Cannasouth was one of the first companies in New Zealand to receive medicinal cannabis research licences for both the cultivation and extraction of cannabinoids.
The company’s goal is to develop next-generation cannabinoid therapeutics to support patient health outcomes and improve their quality of life. 

Mark has been involved in the industrial hemp industry in New Zealand since 1995 and was involved in some of the country’s first licenced hemp growing trials in 2002. Mark’s business background spans 25 years. He is an entrepreneur by nature with a passion for business and has been involved in a number of ventures from initial conception through to mature, well-established companies.  


All Sessions by Mark Lucas

Day 1 - Industry Summit - 10 February

Time Industry Stream Science Stream
09:50
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis

More Speakers

Zoë Reece

Founder and CEO

Anna Yallop

General Manager

Eva Neshat

Founder and Chief Executive Officer